Inhibitors of PI3Kβ as Potential Treatment for Cancer

被引：1
|
作者：
Abdel-Magid, Ahmed F. [1 ]
机构：
[1] Therachem Res Medilab India Pvt Ltd, Jaipur, Rajasthan, India
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2013年 / 4卷 / 09期
关键词：
D O I：
10.1021/ml400274v
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：815 / 816
页数：2
相关论文
共 50 条
  • [41] PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
    Mazzoletti, M.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4433 - 4447
  • [42] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, 12 (04) : 342 - 354
  • [43] The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress
    Bahrami, Afsane
    Khazaei, Majid
    Shahidsales, Soodabeh
    Hassanian, Seyed Mahdi
    Hasanzadeh, Malihe
    Maftouh, Mina
    Ferns, Gordon A.
    Avan, Amir
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (01) : 213 - 222
  • [44] Design, synthesis and bioevaluation of PI3Kα-selective inhibitors as potential colorectal cancer drugs
    Zheng, Xue-Mei
    Chen, Yuan-Si
    Ban, Yu-Juan
    Wang, Yu-Jie
    Dong, Yong-Xi
    Lei, Li
    Guo, Bing
    Wang, Jian-Ta
    Tang, Lei
    Li, Hong-Liang
    Zhang, Ji-Quan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 260
  • [45] Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammation
    Ellard, Katie
    Sunose, Mihiro
    Bell, Kathryn
    Ramsden, Nigel
    Bergamini, Giovanna
    Neubauer, Gitte
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4546 - 4549
  • [46] Taking PI3Kδ and PI3Kγ One Step Ahead: Dual Active PI3Kδ/γ Inhibitors for the Treatment of Immune-Mediated Inflammatory Diseases
    Rommel, Christian
    PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 : 279 - 299
  • [47] Effect of specific PI3K/mTOR inhibitors in squamous lung cancer cells carrying PI3K alterations
    Bonelli, M.
    Cavazzoni, A.
    La Monica, S.
    Galetti, M.
    Caffarra, C.
    Cretella, D.
    Saccani, F.
    Fumarola, C.
    Alfieri, R.
    Petronini, P. G.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S166 - S167
  • [48] Targeting the PI3K/AKT/mTOR pathway: potential for lung cancer treatment
    Cheng, Haiying
    Shcherba, Marina
    Pendurti, Gopichand
    Liang, Yuanxin
    Piperdi, Bilal
    Perez-Soler, Roman
    LUNG CANCER MANAGEMENT, 2014, 3 (01) : 67 - 75
  • [49] Efficacy of PI3K inhibitors to PI3K mutants in enzyme and cell levels
    Dan, Shingo
    Sugita, Hironobu
    Yamazaki, Kanami
    Yamori, Takao
    CANCER RESEARCH, 2009, 69
  • [50] PI3k and MEK kinase inhibitors in lung cancer treatment in a murine transgenic model
    Dardon, J. M.
    BULLETIN DU CANCER, 2009, 96 (01) : 16 - 16
12345